Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma of Lung × Darbepoetin alfa × Clear all

Sponsor

Conditions

Anemia 5 Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Leukemia 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neoplasms, Plasma Cell 2 Mycosis Fungoides 2 Multiple Myeloma 2 Monoclonal Gammopathy of Undetermined Significance 2 Lymphoproliferative Disorders 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Follicular 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Prolymphocytic 2 Leukemia, Mast-Cell 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Large Granular Lymphocytic 2 Leukemia, Hairy Cell 2 Leukemia, Biphenotypic, Acute 2 Immunoglobulin Light-chain Amyloidosis 2

Interventions

Carboplatin 22 Bevacizumab 17 Paclitaxel 16 Pemetrexed 14 Radiotherapy 11 Erlotinib Hydrochloride 11 Docetaxel 7 Gemcitabine 5 Cetuximab 5 ceritinib 4 Taxes 4 Cisplatin 4 pembrolizumab 3 Surgical Procedures, Operative 3 Radiosurgery 3 Metformin 3 Gefitinib 3 Cyclophosphamide 3 pegfilgrastim 2 capmatinib 2 Thalidomide 2 Sorafenib 2 Radiotherapy, Conformal 2 Nivolumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Albumin-Bound Paclitaxel 2 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 2 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡